Copy-number intratumor heterogeneity contributes to predict relapse in chemotherapy-naive stage II colon cancer
Sara Lahoz, Iván Archilla, Elena Asensio, Eva Hernández‐Illán, Queralt Ferrer, Sandra López‐Prades, Ferran Nadeu, Javier del Rey, Rebeca Sanz Pamplona, Juan José Lozano, Antoni Castells, Míriam Cuatrecasas, Jordi Camps
The paper identifies copy-number intratumor heterogeneity as a predictor of relapse in stage II colon cancer, improving risk prediction beyond clinicopathological markers.
bioRxiv · Apr 16, 2021 · PreprintGenomics